Copyright Reports & Markets. All rights reserved.

Global Lyme Disease Diagnostic Service Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Lyme Disease Diagnostic Service Market Size 2017-2028
    • 2.1.2 Lyme Disease Diagnostic Service Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Lyme Disease Diagnostic Service Segment by Type
    • 2.2.1 ELISA
    • 2.2.2 Western Blotting
    • 2.2.3 PCR
    • 2.2.4 Others
  • 2.3 Lyme Disease Diagnostic Service Market Size by Type
    • 2.3.1 Lyme Disease Diagnostic Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Lyme Disease Diagnostic Service Market Size Market Share by Type (2017-2022)
  • 2.4 Lyme Disease Diagnostic Service Segment by Application
    • 2.4.1 Individual
    • 2.4.2 Hospitals and Testing Institutions
    • 2.4.3 Others
  • 2.5 Lyme Disease Diagnostic Service Market Size by Application
    • 2.5.1 Lyme Disease Diagnostic Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Lyme Disease Diagnostic Service Market Size Market Share by Application (2017-2022)

3 Lyme Disease Diagnostic Service Market Size by Player

  • 3.1 Lyme Disease Diagnostic Service Market Size Market Share by Players
    • 3.1.1 Global Lyme Disease Diagnostic Service Revenue by Players (2020-2022)
    • 3.1.2 Global Lyme Disease Diagnostic Service Revenue Market Share by Players (2020-2022)
  • 3.2 Global Lyme Disease Diagnostic Service Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Lyme Disease Diagnostic Service by Regions

  • 4.1 Lyme Disease Diagnostic Service Market Size by Regions (2017-2022)
  • 4.2 Americas Lyme Disease Diagnostic Service Market Size Growth (2017-2022)
  • 4.3 APAC Lyme Disease Diagnostic Service Market Size Growth (2017-2022)
  • 4.4 Europe Lyme Disease Diagnostic Service Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Lyme Disease Diagnostic Service Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Lyme Disease Diagnostic Service Market Size by Country (2017-2022)
  • 5.2 Americas Lyme Disease Diagnostic Service Market Size by Type (2017-2022)
  • 5.3 Americas Lyme Disease Diagnostic Service Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Lyme Disease Diagnostic Service Market Size by Region (2017-2022)
  • 6.2 APAC Lyme Disease Diagnostic Service Market Size by Type (2017-2022)
  • 6.3 APAC Lyme Disease Diagnostic Service Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Lyme Disease Diagnostic Service by Country (2017-2022)
  • 7.2 Europe Lyme Disease Diagnostic Service Market Size by Type (2017-2022)
  • 7.3 Europe Lyme Disease Diagnostic Service Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Lyme Disease Diagnostic Service by Region (2017-2022)
  • 8.2 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Lyme Disease Diagnostic Service Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Lyme Disease Diagnostic Service Market Forecast

  • 10.1 Global Lyme Disease Diagnostic Service Forecast by Regions (2023-2028)
    • 10.1.1 Global Lyme Disease Diagnostic Service Forecast by Regions (2023-2028)
    • 10.1.2 Americas Lyme Disease Diagnostic Service Forecast
    • 10.1.3 APAC Lyme Disease Diagnostic Service Forecast
    • 10.1.4 Europe Lyme Disease Diagnostic Service Forecast
    • 10.1.5 Middle East & Africa Lyme Disease Diagnostic Service Forecast
  • 10.2 Americas Lyme Disease Diagnostic Service Forecast by Country (2023-2028)
    • 10.2.1 United States Lyme Disease Diagnostic Service Market Forecast
    • 10.2.2 Canada Lyme Disease Diagnostic Service Market Forecast
    • 10.2.3 Mexico Lyme Disease Diagnostic Service Market Forecast
    • 10.2.4 Brazil Lyme Disease Diagnostic Service Market Forecast
  • 10.3 APAC Lyme Disease Diagnostic Service Forecast by Region (2023-2028)
    • 10.3.1 China Lyme Disease Diagnostic Service Market Forecast
    • 10.3.2 Japan Lyme Disease Diagnostic Service Market Forecast
    • 10.3.3 Korea Lyme Disease Diagnostic Service Market Forecast
    • 10.3.4 Southeast Asia Lyme Disease Diagnostic Service Market Forecast
    • 10.3.5 India Lyme Disease Diagnostic Service Market Forecast
    • 10.3.6 Australia Lyme Disease Diagnostic Service Market Forecast
  • 10.4 Europe Lyme Disease Diagnostic Service Forecast by Country (2023-2028)
    • 10.4.1 Germany Lyme Disease Diagnostic Service Market Forecast
    • 10.4.2 France Lyme Disease Diagnostic Service Market Forecast
    • 10.4.3 UK Lyme Disease Diagnostic Service Market Forecast
    • 10.4.4 Italy Lyme Disease Diagnostic Service Market Forecast
    • 10.4.5 Russia Lyme Disease Diagnostic Service Market Forecast
  • 10.5 Middle East & Africa Lyme Disease Diagnostic Service Forecast by Region (2023-2028)
    • 10.5.1 Egypt Lyme Disease Diagnostic Service Market Forecast
    • 10.5.2 South Africa Lyme Disease Diagnostic Service Market Forecast
    • 10.5.3 Israel Lyme Disease Diagnostic Service Market Forecast
    • 10.5.4 Turkey Lyme Disease Diagnostic Service Market Forecast
    • 10.5.5 GCC Countries Lyme Disease Diagnostic Service Market Forecast
  • 10.6 Global Lyme Disease Diagnostic Service Forecast by Type (2023-2028)
  • 10.7 Global Lyme Disease Diagnostic Service Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Quidel Corporation
    • 11.1.1 Quidel Corporation Company Information
    • 11.1.2 Quidel Corporation Lyme Disease Diagnostic Service Product Offered
    • 11.1.3 Quidel Corporation Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Quidel Corporation Main Business Overview
    • 11.1.5 Quidel Corporation Latest Developments
  • 11.2 Roche Holding AG
    • 11.2.1 Roche Holding AG Company Information
    • 11.2.2 Roche Holding AG Lyme Disease Diagnostic Service Product Offered
    • 11.2.3 Roche Holding AG Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Roche Holding AG Main Business Overview
    • 11.2.5 Roche Holding AG Latest Developments
  • 11.3 Fujirebio（H.U. Group Holdings）
    • 11.3.1 Fujirebio（H.U. Group Holdings） Company Information
    • 11.3.2 Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Product Offered
    • 11.3.3 Fujirebio（H.U. Group Holdings） Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Fujirebio（H.U. Group Holdings） Main Business Overview
    • 11.3.5 Fujirebio（H.U. Group Holdings） Latest Developments
  • 11.4 ZEUS Scientific
    • 11.4.1 ZEUS Scientific Company Information
    • 11.4.2 ZEUS Scientific Lyme Disease Diagnostic Service Product Offered
    • 11.4.3 ZEUS Scientific Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 ZEUS Scientific Main Business Overview
    • 11.4.5 ZEUS Scientific Latest Developments
  • 11.5 IGeneX
    • 11.5.1 IGeneX Company Information
    • 11.5.2 IGeneX Lyme Disease Diagnostic Service Product Offered
    • 11.5.3 IGeneX Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 IGeneX Main Business Overview
    • 11.5.5 IGeneX Latest Developments
  • 11.6 Thermo Fisher Scientific
    • 11.6.1 Thermo Fisher Scientific Company Information
    • 11.6.2 Thermo Fisher Scientific Lyme Disease Diagnostic Service Product Offered
    • 11.6.3 Thermo Fisher Scientific Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Thermo Fisher Scientific Main Business Overview
    • 11.6.5 Thermo Fisher Scientific Latest Developments
  • 11.7 Everlywell
    • 11.7.1 Everlywell Company Information
    • 11.7.2 Everlywell Lyme Disease Diagnostic Service Product Offered
    • 11.7.3 Everlywell Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Everlywell Main Business Overview
    • 11.7.5 Everlywell Latest Developments
  • 11.8 Oxford Immunotec Global PLC(PerkinElmer)
    • 11.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Information
    • 11.8.2 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Product Offered
    • 11.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Oxford Immunotec Global PLC(PerkinElmer) Main Business Overview
    • 11.8.5 Oxford Immunotec Global PLC(PerkinElmer) Latest Developments
  • 11.9 BioMerieux
    • 11.9.1 BioMerieux Company Information
    • 11.9.2 BioMerieux Lyme Disease Diagnostic Service Product Offered
    • 11.9.3 BioMerieux Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 BioMerieux Main Business Overview
    • 11.9.5 BioMerieux Latest Developments
  • 11.10 Bio-Rad Laboratories
    • 11.10.1 Bio-Rad Laboratories Company Information
    • 11.10.2 Bio-Rad Laboratories Lyme Disease Diagnostic Service Product Offered
    • 11.10.3 Bio-Rad Laboratories Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Bio-Rad Laboratories Main Business Overview
    • 11.10.5 Bio-Rad Laboratories Latest Developments
  • 11.11 T2 Biosystems
    • 11.11.1 T2 Biosystems Company Information
    • 11.11.2 T2 Biosystems Lyme Disease Diagnostic Service Product Offered
    • 11.11.3 T2 Biosystems Lyme Disease Diagnostic Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 T2 Biosystems Main Business Overview
    • 11.11.5 T2 Biosystems Latest Developments

12 Research Findings and Conclusion

The global market for Lyme Disease Diagnostic Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Lyme Disease Diagnostic Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Lyme Disease Diagnostic Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Lyme Disease Diagnostic Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Lyme Disease Diagnostic Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Lyme Disease Diagnostic Service players cover Quidel Corporation, Roche Holding AG, Fujirebio（H.U. Group Holdings）, ZEUS Scientific and IGeneX, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Lyme Disease Diagnostic Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Lyme Disease Diagnostic Service market, with both quantitative and qualitative data, to help readers understand how the Lyme Disease Diagnostic Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Lyme Disease Diagnostic Service market and forecasts the market size by Type (ELISA, Western Blotting and PCR), by Application (Individual, Hospitals and Testing Institutions and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
ELISA
Western Blotting
PCR
Others

Segmentation by application
Individual
Hospitals and Testing Institutions
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Quidel Corporation
Roche Holding AG
Fujirebio（H.U. Group Holdings）
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems

Chapter Introduction
Chapter 1: Scope of Lyme Disease Diagnostic Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Lyme Disease Diagnostic Service market size and CAGR, Lyme Disease Diagnostic Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lyme Disease Diagnostic Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lyme Disease Diagnostic Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lyme Disease Diagnostic Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Quidel Corporation, Roche Holding AG, Fujirebio（H.U. Group Holdings）, ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer) and BioMerieux, etc.
Chapter 14: Research Findings and Conclusion
Buy now